Prediction of miscarriage and stillbirth at 11-13 weeks and the contribution of chorionic villus sampling

Prenatal Diagnosis

Volumn 31, Issue 1, 2011, Pages 38-45

  Akolekar, Ranjit ^a   Bower, Sarah ^a   Flack, Nicola ^a   Bilardo, Caterina M ^b   Nicolaides, Kypros H ^a,c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chorionic villus sampling; Ductus venosus; First trimester screening; Miscarriage; Nuchal translucency; Pregnancy associated plasma protein A; Stillbirth

Indexed keywords

PREGNANCY ASSOCIATED PROTEIN;

A WAVE; ANEUPLOIDY; ARTICLE; CHORION VILLUS SAMPLING; CIGARETTE SMOKING; DIABETES MELLITUS; DUCTUS VENOSUS; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; OVULATION; OVULATION INDUCTION; PREDICTION; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; SPONTANEOUS ABORTION; STATISTICAL MODEL; STILLBIRTH; VEIN BLOOD FLOW; WEIGHT;

ABORTION, SPONTANEOUS; ADULT; BODY WEIGHT; CHORIONIC VILLI SAMPLING; CONTINENTAL POPULATION GROUPS; FALSE POSITIVE REACTIONS; FEMALE; FETAL HEART; GESTATIONAL AGE; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RISK FACTORS; STILLBIRTH;

EID: 78650821444     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2644     Document Type: Article

References (34)

1. Aliyu MH, Lynch O, Wilson RE, et al. 2010. Association between tobacco use in pregnancy and placenta-associated syndromes: a population-based study. Arch Gynecol Obstet. DOI: 10.1007/s00404-010-1447-8.
2. Bhattacharya S, Townend J, Bhattacharya S. 2010. Recurrent miscarriage: are three miscarriages one too many? Analysis of a Scottish population-based database of 151, 021 pregnancies. Eur J Obstet Gynecol Reprod Biol 150: 24-27.
3. Bilardo CM, Müller MA, Pajkrt E, et al. 2007. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Ultrasound Obstet Gynecol 30: 11-18.
4. Centre for Maternal and Child Enquiries (CMACE). 2010. Perinatal Mortality 2008: United Kingdom CMACE: London.
5. Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. 1996. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 11: 2623-2628.
6. Dugoff L, Cuckle HS, Hobbins JC, et al., FaSTER Trial Research Consortium. 2008. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers. Am J Obstet Gynecol 199: 290.e1-290.e6.
7. Fretts RC. 2005. Etiology and prevention of stillbirth. Am J Obstet Gynecol 193: 1923-1935.
8. Högberg L, Cnattingius S. 2007. The influence of maternal smoking habits on the risk of subsequent stillbirth: is there a causal relation?. BJOG 114: 699-704.
9. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. 2008. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A. Ultrasound Obstet Gynecol 31: 618-624.
10. Macintosh MC, Fleming KM, Bailey JA, et al. 2006. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333: 177.
11. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH. 2008. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 64 weeks of gestation. Obstet Gynecol 112: 598-605.
12. Maiz N, Valencia C, Kagan KO, Wright D, Nicolaides KH. 2009. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 33: 512-517.
13. Metwally M, Ong KJ, Ledger WL, Li TC. 2008. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 90: 714-726.
14. Mills JL, Simpson JL, Driscoll SG, et al. 1988. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 319: 1617-1623.
15. Nicolaides KH. 2011. Screening for aneuploidies at 11-13 weeks. Prenatal Diagn 31(1): 7-15.
16. Nicolaides KH, Brizot M, Patel F, Snijders R. 1994. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet 344: 435-439.
17. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. 2000. Maternal age and fetal loss: population based register linkage study. BMJ 320: 1708-1712.
18. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH. 2011. Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates. Prenat Diagn 31(1): 58-65.
19. Robinson HP, Fleming JE. 1975. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 182: 702-710.
20. Sebire NJ, Jolly M, Harris JP, et al. 2001. Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 25: 1175-1182.
21. Smith GC, Shah I, White IR, Pell JP, Crossley JA, Dobbie R. 2007. Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG 114: 705-714.
22. Smith GC, Fretts RC. 2007. Stillbirth. Lancet 370: 1715-1725.
23. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. Fetal Medicine Foundation First Trimester Screening Group. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
24. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. 2001. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18: 9-17.
25. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. 2005. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 192: 1005-1021.
26. Spencer K, Cowans NJ, Avgidou K, Nicolaides KH. 2006. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Ultrasound Obstet Gynecol 28: 637-643.
27. Stephansson O, Dickman PW, Johansson A, Cnattingius S. 2001. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol 184: 463-469.
28. Surkan PJ, Stephansson O, Dickman PW, Cnattingius S. 2004. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. N Engl J Med 350: 777-785.
29. Sundberg K, Bang J, Smidt-Jensen S, et al. 1997. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 350: 697-703.
30. Tabor A, Philip J, Madsen M, et al. 1986. Randomised controlled trial of genetic amniocentesis in 4, 606 low-risk women. Lancet 1: 1287-1293.
31. Tabor A, Alfirevic Z. 2010. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 27: 1-7.
32. Wang JX, Norman RJ, Wilcox AJ. 2004. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod 19: 272-277.
33. Willinger M, Ko CW, Reddy UM. 2009. Racial disparities in stillbirth risk across gestation in the United States. Am J Obstet Gynecol 201: 469.e1-469.e8.
34. Zhang X, Mumford SL, Cnattingius S, Schisterman EF, Kramer MS. 2010. Reduced birthweight in short or primiparous mothers: physiological or pathological?. BJOG. DOI: 10.1111/j.1471-0528.2010.02642.